Table 3.

Fusion profile of the DO2 muscle for wild type and fusion mutant embryos.

Genotype	Stage 12	Stage 13	Stage 14	Stage 15	% lacking fusion*
Wild type	1.04 ± 0.20 (1–2)	2.60 ± 1.01 (1–5)	5.42 ± 2.00 (3–9)	10.76 ± 1.82 (8–17)	0%
blow	0.94 ± 0.24 (0–1)	1.04 ± 0.28 (0–2)	1.16 ± 0.47 (0–3)	1.24 ± 0.74 (0–3)	64%
kette	1.04 ± 0.20 (1–2)	1.18 ± 0.52 (0–3)	1.80 ± 0.88 (0–4)	1.84 ± 0.98 (0–4)	32%
loner	1.02 ± 0.25 (0–2)	1.10 ± 0.30 (1–2)	1.12 ± 0.33 (1–2)	1.06 ± 0.42 (0–2)	82%
mbc	0.98 ± 0.14 (0–1)	1.02 ± 0.14 (1–2)	1.00 ± 0.35 (0–2)	1.04 ± 0.40 (0–3)	90%
rac	1.04 ± 0.28 (0–2)	1.56 ± 0.64 (0–3)	2.90 ± 1.25 (0–5)	5.50 ± 1.42 (3–9)	0%
rols	1.08 ± 0.27 (1–2)	1.14 ± 0.35 (1–2)	1.62 ± 0.60 (0–3)	2.28 ± 0.78 (0–4)	8%

For each stage and genotype the average number of nuclei +/− standard deviation are shown (n=50). The range of nuclei numbers observed are shown in brackets.

^*% of hemisegments lacking any fusion at stage 15 (n=50).